Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock
5 years ago

Coronavirus outbreak: Govt restrains exports of a few APIs, formulations; lists essential medicines that could run out of stock

Firstpost  

In a notification, the government put curbs on the exports of certain APIs and formulations, including Paracetamol, Vitamin B1 and B12 amid the coronavirus outbreak claimed over 3,000 lives across the world. CNBC-TV18 newsbreak confirmed, here is the list of APIs that have been put in the list of restriction for exports by the government pic.twitter.com/H0cMra60y1 — CNBC-TV18 March 3, 2020 In a notification, the government put curbs on the exports of certain active pharmaceutical ingredients and formulations, including Paracetamol, Vitamin B1 and B12 amid the coronavirus outbreak claimed over 3,000 lives across the world, reported PTI. On 26 February this year, Sandoz, a global generics major, had said that it would ensure stable pricing for a basket of essential medicines the company markets, which may help treat coronavirus patients, amid growing concerns about the potential impact of the outbreak on global supply chains. “That’s why, with immediate effect, and despite current uncertainties about how the supply situation will evolve, Sandoz is committing as an initial response to keep prices stable for certain essential medicines it markets commercially, which may help in the treatment of coronavirus cases, specifically antivirals to reduce the impact of coronavirus and antibiotics to combat pneumonia,” he said.

India China Coronavirus Exports Report Cnbc Medicines Sandoz Apis Essential Medicines Formulations Coronavirus Outbreak  govt  report  restrains  formulations  run  apis  pharmaceutical  coronavirus  lists  supply  ingredients  essential  stock  outbreak  medicines  exports

History of this topic

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India
4 months, 2 weeks ago

Chinese Pharma Major Shanghai Pharma Seeking API Imports From India

ABP News  

Shanghai, China: Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients from India, and is also planning to invest in the Indian market in an effort to expand its footprint in the generic drugs market. In India, more and more APIs are getting FDA approval, so we are now thinking of importing APIs from …

'Cannot Export Products Made for Sale in Indian Market': Health Regulator Issues Alert
1 year, 2 months ago

'Cannot Export Products Made for Sale in Indian Market': Health Regulator Issues Alert

News 18  

Products made for the Indian market cannot be exported, the central health regulator has said in an alert issued to all of its port offices across India, asking them to watch the exports by merchant exporters, News18 has learnt. The notice issued by the Drugs Controller General of India said: “It came to notice that products meant for Sale in …

Nigeria Tightens Regulations on Indian Pharma Exports, New Standards May Spark Industry Concerns
1 year, 2 months ago

Nigeria Tightens Regulations on Indian Pharma Exports, New Standards May Spark Industry Concerns

News 18  

The Nigerian drug regulator has recently heightened its standards for Indian drug makers exporting to the country, News18 has learnt. According to the National Agency for Food and Drug Administration and Control — the health regulator of Nigeria — the quality of Active Pharmaceutical Ingredients used in finished pharmaceutical products manufacturing directly impacts the “safety, efficacy, quality, regulatory compliance, consistency, …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year, 4 months ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

Govt orders study to gauge hurdles in producing APIs
1 year, 6 months ago

Govt orders study to gauge hurdles in producing APIs

Live Mint  

NEW DELHI : In order to strengthen the domestic production of Active Pharmaceuticals Ingredients, the Department of Pharmaceuticals is conducting a first-of-its-kind study on the gaps and challenges in the sector. In this regard, all pharma companies and drug manufacturing associations have been asked to share the import and export data of APIs for analyzing the domestic industry, financial gaps …

Budget 2023: An Opportunity To Push India's Pharma Industry Development
2 years, 2 months ago

Budget 2023: An Opportunity To Push India's Pharma Industry Development

News 18  

The Union Budget 2023-24 will be presented on February 1 against the backdrop of a global recessionary fear. Several public sector schemes launched in the past few years, including the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, have focused on building last-mile infrastructure. Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance Secretary General Sudarshan …

Exporters on edge as raging covid in China derails trade
2 years, 3 months ago

Exporters on edge as raging covid in China derails trade

Live Mint  

The covid-19 surge in China has triggered concern among Indian exporters as it may add to the softening of demand from Western countries. China, India’s largest trading partner, reported an 11% decline in imports in November, and the latest outbreak could further hit exports of Indian goods. “The covid situation in China is a cause for concern both in terms …

What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?
2 years, 7 months ago

What is Active Pharmaceutical Ingredient and why is it essential for drug manufacturing?

Firstpost  

The COVID-19 pandemic caused a panic among global pharmaceutical manufacturers as the supply of APIs was disrupted from China, the world’s largest producer Active Pharmaceutical Ingredients or APIs are essential to the pharma industry. According to pharmaceutical company Biocon, an API means “the biologically active component of a drug product that produces the intended effects”. The COVID-19 pandemic caused a …

Government removes export curbs on all diagnostic kits, reagents amid declining COVID-19 cases
3 years, 5 months ago

Government removes export curbs on all diagnostic kits, reagents amid declining COVID-19 cases

Firstpost  

The export restrictions on these products were imposed in June last year and 16 August, 2021 on account of increasing COVID-19 cases New Delhi: With COVID-19 cases coming down in the country, the government on Friday removed export curbs on all diagnostic kits and reagents including instruments, which are used in detection of coronavirus infections. “The export policy of all …

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December
3 years, 5 months ago

India May Speed Up Covid-19 Vaccine Exports Under Maitri Programme By December

News 18  

Anticipating excess stock of Covid-19 vaccines, India may accelerate the export under its humanitarian initiative — Vaccine Maitri — by December, News18.com has learnt. “As soon as we will get into a situation where we will have vaccine stock more than the requirement of Indian population, we will accelerate the exports to serve the requirement of other nations,” a senior …

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China
3 years, 8 months ago

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China

News 18  

The Indian pharmaceutical industry is one of the major contributors to the Indian economy and it is the world’s third-largest industry by volume. As the world’s top supplier of bulk drugs and formulations, Indian pharmaceutical plants consistently attract the highest number of FDA approvals outside of the US, and the country submits more than 40 per cent of all global …

Centre Eases Export Policy Over Remdesivir Injection, Drug Now In 'Restricted' Category
3 years, 9 months ago

Centre Eases Export Policy Over Remdesivir Injection, Drug Now In 'Restricted' Category

ABP News  

Centre on Monday lifted the two-month-long ban on the export of Remdesivir drug, allowing overseas sales without “special” authorization. The Government of India on June 14 amended the export policy for injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients, permitting the export of the drug used in COVID-19 treatment with immediate effect. In a notification issued on June 14, the Ministry …

U.S. vaccine ‘gift’ to India may not be substantial
3 years, 9 months ago

U.S. vaccine ‘gift’ to India may not be substantial

The Hindu  

The government on Friday welcomed the U.S. decision to lift restrictions under its Defence Production Act on the export of vaccine ingredients to AstraZeneca vaccine manufacturers worldwide, which would help the Serum Institute of India produce more doses. “Indian diplomacy is focussed on securing the vaccine supply chain,” said External Affairs Minister S. Jaishankar, who had raised the issue of …

PIL in HC Seeks All Remdesivir Makers Be Allowed to Sell it in Domestic Market
3 years, 10 months ago

PIL in HC Seeks All Remdesivir Makers Be Allowed to Sell it in Domestic Market

News 18  

The Delhi High Court on Monday asked the Centre and various pharma majors to respond to a PIL seeking that all drug firms making Remdesivir, used in Covid-19 treatment, be allowed to sell it in the domestic market. A bench of Chief Justice D N Patel and Justice Jasmeet Singh issued notice to the Health Ministry, Central Drugs Standard Control …

US to export vaccine raw material, deploy expert team to help India after NSA Doval's call with counterpart
3 years, 11 months ago

US to export vaccine raw material, deploy expert team to help India after NSA Doval's call with counterpart

India Today  

The United States on Sunday identified sources of specific raw material urgently required by Pune-based Serum Institute of India to produce the Oxford-AstraZeneca coronavirus vaccine - Covishield. "To help treat Covid-19 patients and protect front-line health workers in India, the United States has identified supplies of therapeutics, rapid diagnostic test kits, ventilators, and Personal Protective Equipment that will immediately be …

US Defends Export Ban of Covid Vaccine Raw to India, Says 'Americans First'
3 years, 11 months ago

US Defends Export Ban of Covid Vaccine Raw to India, Says 'Americans First'

News 18  

Defending US’ restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India’s vaccination drive, a senior State Department official has said the Biden administration’s first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India’s request to lift a …

U.S. defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban
3 years, 11 months ago

U.S. defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban

The Hindu  

Defending U.S.’ restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India’s vaccination drive, a senior State Department official has said the Biden administration’s first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India’s request to lift a …

US defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban
3 years, 11 months ago

US defends restrictions on export of COVID-19 vaccine raw materials amid India's request to lift ban

India TV News  

Defending US' restrictions on the export of key raw materials for the manufacture of COVID-19 vaccine that threatens to slow India's vaccination drive, a senior State Department official has said the Biden administration's first obligation is to take care of the requirements of the American people. When asked when the Biden administration would decide on India''s request to lift a …

'Understand India's pharmaceutical needs': US to consider lifting ban on Covid-19 vaccine raw material supply
3 years, 11 months ago

'Understand India's pharmaceutical needs': US to consider lifting ban on Covid-19 vaccine raw material supply

India TV News  

The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter a due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption. During his meetings with the US …

We understand India’s pharmaceutical requirements: Joe Biden
3 years, 11 months ago

We understand India’s pharmaceutical requirements: Joe Biden

The Hindu  

The Biden administration has conveyed to New Delhi that it understands India’s pharmaceutical requirements and promised to give the matter a due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption. President Joe Biden and his predecessor …

India's Covid-19 cases mount but uncertainty over US export ban on vaccine raw materials continues
3 years, 11 months ago

India's Covid-19 cases mount but uncertainty over US export ban on vaccine raw materials continues

India Today  

Serum Institute of India's Chief Executive Officer, Adar Poonawalla recently sought US President Joe Biden's intervention in lifting a ban on raw materials that India imports from the US. SoS FROM POONAWALLA On April 16, Adar Poonawalla, in what appeared to be a desperate appeal, tweeted: "Respected @POTUS, if we are to truly unite in beating this virus, on behalf …

India to waive import duty on Covid-19 vaccines: Report
3 years, 11 months ago

India to waive import duty on Covid-19 vaccines: Report

India Today  

India will waive its 10 per cent customs duty on imported Covid-19 vaccines, a senior government official told Reuters on Monday, as it tries to boost supplies to counter a dramatic surge in coronavirus cases. Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and Johnson to sell …

Despite Spurt In Cases, Govt Worried About Banning Commercial Export of Covid-19 Vaccine
3 years, 11 months ago

Despite Spurt In Cases, Govt Worried About Banning Commercial Export of Covid-19 Vaccine

News 18  

A special report by Moneycontrol has confirmed that the Centre has decided against banning the commercial export of Covid-19 vaccines by the two manufacturers based in India. Reports of acute shortage of vaccine doses in many States also prompted calls to stop the export of the Covishield vaccine manufactured by Pune’s Serum Institute of India and Covaxin, made by Hyderabad-based …

India bans export of remdesivir till COVID situation improves
3 years, 11 months ago

India bans export of remdesivir till COVID situation improves

India TV News  

India bans export of remdesivir till COVID situation improves In view of increased demand for remdesivir due to a surge in COVID-19 cases, the Centre on Sunday said the export of the antiviral injection and its Active Pharmaceutical Ingredients has been banned till the situation improves. In view of increased demand for remdesivir due to a surge in COVID-19 cases, …

Coronavirus | India bans export of Remdesivir
3 years, 11 months ago

Coronavirus | India bans export of Remdesivir

The Hindu  

Centre has prohibited the exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients in an order issued on Sunday stating that there has been a sudden spike in demand for injection Remdesivir used in treatment of COVID patients. “India is witnessing a recent surge in COVID cases and there is a potential of further increase in demand for injection Remdesivir …

Centre bans export of Remdesivir amid crunch, eases access of Covid patients to anti-viral drug
3 years, 11 months ago

Centre bans export of Remdesivir amid crunch, eases access of Covid patients to anti-viral drug

India Today  

With India staring at the second wave of Covid-19 infections, the central government on Sunday prohibited the export of Remdesivir. A number of companies in India produce Injection Remdesivir under a voluntary licensing agreement with US pharma giant Gilead Sciences. The central government also said that steps are being taken to ensure that hospitals and Covid-19 patients have easy access …

India bans remdesivir exports as COVID-19 cases surge
3 years, 11 months ago

India bans remdesivir exports as COVID-19 cases surge

Al Jazeera  

The health ministry says a ban to be in place until the ‘situation improves’ as India sees the sixth record daily rise in new infections in seven days. India has banned the export of antiviral drug remdesivir and its active pharmaceutical ingredients as demand rocketed amid a record surge in COVID-19 infections and led to shortages in many parts of …

India’s COVID-19 vaccine export may be curbed
4 years ago

India’s COVID-19 vaccine export may be curbed

The Hindu  

Amidst a fresh surge in COVID-19 cases in India, and the rollout of vaccines for those above 45 years from April 1, the government has hinted it may need to “calibrate” its supply schedules to other countries, although it has not proposed a full ban on exports at this time. According to Global vaccine alliance GAVI, which runs the COVAX …

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge: Report
4 years ago

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge: Report

India Today  

India has put a temporary hold on all major exports of the AstraZeneca coronavirus vaccine made by the Serum Institute of India to meet demand at home as infections rise, two sources told Reuters. The move will also affect supplies to the GAVI/WHO-backed COVAX vaccine-sharing facility through which more than 180 countries are expected to get doses, one of the …

India, ‘pharmacy of the world’, starts exporting COVID vaccines
4 years, 2 months ago

India, ‘pharmacy of the world’, starts exporting COVID vaccines

Al Jazeera  

First shipment sent to Bhutan as ‘supplies under grant assistance’ to be exported to other neighbouring nations. India has started exporting coronavirus vaccines with a shipment to the neighbouring Himalayan kingdom of Bhutan, the Ministry of External Affairs said, as the so-called “pharmacy of the world” looks to bolster its vaccine diplomacy. Many low and middle-income countries are relying on …

India to start Covid-19 vaccine exports from tomorrow: Report
4 years, 2 months ago

India to start Covid-19 vaccine exports from tomorrow: Report

Live Mint  

India, one of the world's biggest drugmakers, will start exports of Covid-19 vaccines as early as Wednesday, government sources said, paving the way for many mid-and lower-income countries to secure supplies of the easy-to-store Oxford/AstraZeneca vaccine. Two million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India, will also be despatched to …

India Will Not Allow Export of Covid-19 Vaccine for Several Months, Says Adar Poonawalla
4 years, 2 months ago

India Will Not Allow Export of Covid-19 Vaccine for Several Months, Says Adar Poonawalla

News 18  

India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday. The vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn’t export …

Can India still be ’pharmacy of the world’ while reducing import dependence of APIs?
4 years, 6 months ago

Can India still be ’pharmacy of the world’ while reducing import dependence of APIs?

Live Mint  

New Delhi: After Covid-19 pandemic, India's focus to reduce import dependence of Active Pharmaceutical Ingredients and key starting material for drug manufacturing might just affect the country's position as the 'pharmacy of the world'. However, self-reliance has also been necessitated due to the sharp rise in prices of APIs sourced from China in recent years,” said Gurpreet Sandhu, President, Council …

India initiates probe against alleged dumping of Vitamin C from China
4 years, 6 months ago

India initiates probe against alleged dumping of Vitamin C from China

India TV News  

India has initiated a probe into the alleged dumping of Vitamin C, used by pharmaceutical firms for the production of medicines, from China following complaint by a domestic manufacturer. The company alleged that the domestic industry is impacted due to the dumping of Vitamin C from China PR and has requested for the imposition of anti-dumping duty on the imports, …

Boycotting Chinese products: Bravado is no substitute for business
4 years, 8 months ago

Boycotting Chinese products: Bravado is no substitute for business

The Hindu  

AN angry man cannot use his brains fully. He said that his company, which has a base in China, was unlikely to be affected adversely because China’s reliance on India was “minuscule” in the context of its overall trade. “Is it not ironical that while the Indian government has adamantly refused to be a part of the Belt and Road …

Dev 360 | Medicine and frontiers: The challenge that China poses
4 years, 9 months ago

Dev 360 | Medicine and frontiers: The challenge that China poses

Deccan Chronicle  

Can India challenge Chinese dominance in pharmaceutical ingredients? Chinese pharmaceutical companies supported by their government set up large fermentation units to mass-produce bulk drugs and intermediates and, at the same time also established intermediates and bulk drug facilities for manufacturing by chemical synthesis route,” says a 2014 white paper by the Indian Drug Manufacturers’ Association. “Indian pharma companies who were …

India lifts export ban on hydroxychloroquine
4 years, 9 months ago

India lifts export ban on hydroxychloroquine

The Hindu  

India has lifted export ban on hydroxychloroquine, the anti-malarial drug touted by U.S. President Donald Trump as a potential “game changer” in the fight against the COVID-19 pandemic. Leading exporter The country, a leading exporter of generic medicines across the world, banned the export of the drug and its formulations in March as the coronavirus outbreak disrupted supply chains. British …

Govt lifts ban on export of hydroxychloroquine with some riders
4 years, 9 months ago

Govt lifts ban on export of hydroxychloroquine with some riders

Live Mint  

NEW DELHI: The department of pharmaceuticals has approved lifting the ban on export of controversial anti-malarial drug hydroxychloroquine, with the condition that manufacturers supply one-fifth of their production to the Indian market, chemicals minister D.V. The DGFT had, on 4 April, banned export of hydroxychloroquine, which is being used to treat covid-19 based on limited evidence. Two Indian firms, Ipca …

How the coronavirus explosed US’ reliance on India and China for generic drugs
4 years, 10 months ago

How the coronavirus explosed US’ reliance on India and China for generic drugs

CNN  

CNN — Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to treat her lupus, a chronic condition that causes unbearable joint pain, fatigue and fainting spells. “The scenario really scared me, what would happen to me if I couldn’t get HCQ?” The US Food and Drug Administration has not approved HCQ as the …

India supplied paracetamol, hydroxychloroquine to over 120 countries in last 2 mths: Goyal
4 years, 10 months ago

India supplied paracetamol, hydroxychloroquine to over 120 countries in last 2 mths: Goyal

India TV News  

India has supplied paracetamol and hydroxychloroquine to over 120 countries in the last two months while ensuring the domestic supply, as these two medicines are in huge demand due to COVID-19, Commerce and Industry Minister Piyush Goyal said on Thursday. Goyal said that India has put restrictions on exports of these medicines with an intention to ensure that not only …

India to send nearly 1,000 tonne of paracetamol raw material to Europe; eases export curbs on over-the-counter medicines
4 years, 10 months ago

India to send nearly 1,000 tonne of paracetamol raw material to Europe; eases export curbs on over-the-counter medicines

Firstpost  

Europe is India’s biggest buyer of paracetamol APIs and imports around 12,000 tonnes annually, according to Pharmexcil estimates. New Delhi: India will supply Europe with about 1,000 tonnes of the active pharmaceutical ingredient for common pain reliever paracetamol, a top exports body said, easing export controls on over-the counter medicines used to cope with COVID-19 symptoms. Europe has sought up …

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions
4 years, 11 months ago

Coronavirus outbreak highlighted vulnerabilities in medical manufacturing supply chain: Fitch Solutions

Firstpost  

New Delhi: With pharmaceutical supply chains under immense pressure due to COVID-19, China’s role as a global ingredient producer has come under scrutiny, Fitch Solutions has said. As per the report, as trade war has heightened discussion over the national security implications of manufacturing new technologies abroad, COVID-19 has highlighted vulnerabilities in the medical manufacturing supply chain, most notably in …

UN chief salutes India for supplying hydroxychloroquine to other countries
4 years, 11 months ago

UN chief salutes India for supplying hydroxychloroquine to other countries

Op India  

Responding to a question on the reaction of UN chief Antonio Guterres to India’s efforts to send Hydroxychloroquine and other supplies to other countries amidst the Wuhan coronavirus outbreak, Guterres’ spokesperson Stephane Dujarric said he ‘salutes’ India and other countries helping others in the global fight against the coronavirus pandemic. After India sent supplies of the anti-malarial drug hydroxychloroquine to …

How an anti-malarial drug has become a tool of India’s diplomacy
4 years, 11 months ago

How an anti-malarial drug has become a tool of India’s diplomacy

Al Jazeera  

India, one of the largest producers of HCQ now used in coronavirus treatment, is exporting the drug to many countries. New Delhi, India – Days after India banned the export of pharmaceuticals amid the coronavirus pandemic, it reversed its decision after US President Donald Trump last week demanded New Delhi ship anti-malarial drug hydroxychloroquine to the United States. India, dubbed …

Coronavirus Outbreak: India agrees to sell hydroxychloroquine to Malaysia to help fight pandemic;
4 years, 11 months ago

Coronavirus Outbreak: India agrees to sell hydroxychloroquine to Malaysia to help fight pandemic;

Firstpost  

Malaysia has been using hydroxychloroquine for mild to severe COVID-19 cases along with other drugs. New Delhi/Kuala Lumpur: India has agreed to sell hydroxychloroquine tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters on Wednesday, with New Delhi partially lifting its bar on exports of the anti-malarial drug. “On 14 April, India has …

Coronavirus | India to get 15 million PPE kits from China
4 years, 11 months ago

Coronavirus | India to get 15 million PPE kits from China

The Hindu  

Indian companies and government entities have placed orders for 15 million Personal Protective Equipment kits, including gowns and masks, and 1.5 million rapid testing kits from China, officials said on Tuesday. and nearly 1.5 million rapid testing kits of all kinds, some of which have already been delivered,” India’s Ambassador to China Vikram Misri said at an online press briefing …

India's malaria drug powers global coronavirus war
4 years, 11 months ago

India's malaria drug powers global coronavirus war

India Today  

An ever-rising global demand for anti-malarial drug Hydroxychloroquine or HCQ to treat Coronavirus patients has turned the spotlight on India. As India said that it would help countries that need HCQ, US President Trump tweeted: "Extraordinary times require even closer cooperation between friends. When producing at its peak capacity, India would be able to produce 35 crore of Hydroxychloroquine tablets …

India revokes ban on export of hydroxychloroquine, drug used in treatment for COVID-19
4 years, 11 months ago

India revokes ban on export of hydroxychloroquine, drug used in treatment for COVID-19

The Hindu  

The Government of India announced on Tuesday that it had rescinded its earlier ban on the export of malaria drug hydroxychloroquine, which is now being used in countries such as the U.S. as a possible line of treatment for COVID-19, setting off a controversy over whether the two-day old blanket ban was overturned under pressure from Washington. The MEA indicated …

India relents on the blanket ban of hydroxychloroquine export, will license to some 'badly affected' nations
4 years, 11 months ago

India relents on the blanket ban of hydroxychloroquine export, will license to some 'badly affected' nations

Op India  

India had recently put a blanket ban on the export of hydroxychloroquine keeping in view the increasing domestic demand amidst the rising cases of Wuhan coronavirus. In view of the humanitarian aspects of #COVID19 pandemic, it has been decided that India would licence paracetamol & Hydroxychloroquine in appropriate quantities to all our neighbouring countries who are dependent on our capabilities: …

Government relaxes export curbs on 24 pharma ingredients, medicines
4 years, 11 months ago

Government relaxes export curbs on 24 pharma ingredients, medicines

India TV News  

Export curbs on 24 pharma ingredients and medicines were relaxed by the Indian government on Monday. However, export restrictions on paracetamol and formulations made of paracetamol would remain, the notification by the Directorate General of Foreign Trade stated. "24 APIs and formulations made from these APIs are made free for export with immediate effect," the DGFT said. Meanwhile, US President …

Discover Related